Cargando…

Comparative study of 1+PRN ranibizumab versus bevacizumab in the clinical setting

PURPOSE: We compared the efficacy of intravitreal ranibizumab and bevacizumab for treating neovascular age-related macular degeneration using an on-demand regimen. METHODS: A total of 186 wet age-related macular degeneration eyes of 186 treatment-naïve patients were compared retrospectively (67 eyes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carneiro, Angela M, Mendonça, Luis S, Falcão, Manuel S, Fonseca, Sofia L, Brandão, Elisete M, Falcão-Reis, Fernando M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422156/ https://www.ncbi.nlm.nih.gov/pubmed/22973087 http://dx.doi.org/10.2147/OPTH.S33017

Ejemplares similares

Isolated Foveal Hypoplasia: Tomographic, Angiographic and Autofluorescence Patterns
por: Mota, Ágata, et al.
Publicado: (2012)

Multimodal Image Analysis in Acquired Vitelliform Lesions and Adult-Onset Foveomacular Vitelliform Dystrophy
por: Rocha Bastos, Ricardo, et al.
Publicado: (2016)

Multimodal Imaging of Acquired Vitelliform Lesion Diagnosed at Pseudohypopyon Stage
por: Gonçalves, Nuno Moreira, et al.
Publicado: (2013)

Ranibizumab in Diabetic Macular Oedema – A Benefit–risk Analysis of Ranibizumab 0.5 mg PRN Versus Laser Treatment
por: Ziemssen, Focke, et al.
Publicado: (2017)

Choroidal and macular thickness changes induced by cataract surgery
por: Falcão, Manuel S, et al.
Publicado: (2014)

Two Novel Disease-Causing Variants in the PDE6C Gene Underlying Achromatopsia
por: Madeira, Carolina, et al.
Publicado: (2021)

Combination of Intravitreal Ranibizumab and Laser Photocoagulation for Aggressive Posterior Retinopathy of Prematurity
por: Mota, Ágata, et al.
Publicado: (2012)

A Clear Cell Renal Cell Carcinoma Inhibiting the Response to Intravitreal Antivascular Endothelial Growth Factor Therapy in Wet Age-Related Macular Disease
por: Falcão, Manuel S., et al.
Publicado: (2012)

Immediate effect of intravitreal injection of bevacizumab on intraocular pressure
por: Lemos-Reis, Ricardo, et al.
Publicado: (2014)

Idiopathic Acute Exudative Polymorphous Vitelliform Maculopathy: Insight into Imaging Features and Outcomes
por: Torres-Costa, Sónia, et al.
Publicado: (2020)

Increased Choroidal Thickness in Keratoconus Patients: Perspectives in the Disease Pathophysiology
por: Pinheiro-Costa, João, et al.
Publicado: (2019)

Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen
por: Lai, Kunbei, et al.
Publicado: (2018)

Lasting Controversy on Ranibizumab and Bevacizumab
por: Zou, Lihui, et al.
Publicado: (2011)

Transepithelial accelerated versus conventional corneal collagen crosslinking in patients with keratoconus: a comparative study
por: Madeira, Carolina, et al.
Publicado: (2019)

Initial Dose of Three Monthly Intravitreal Injections versus PRN Intravitreal Injections of Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Ahn, Seong Joon, et al.
Publicado: (2013)

Anatomical and functional responses in eyes with diabetic macular edema treated with “1 + PRN” ranibizumab: one-year outcomes in population of mainland China
por: Lai, Kunbei, et al.
Publicado: (2020)

PRN Medicines Optimization and Nurse Education
por: Vaismoradi, Mojtaba, et al.
Publicado: (2020)

Comparative role of intravitreal ranibizumab versus bevacizumab in choroidal neovascular membrane in age-related macular degeneration
por: Biswas, Partha, et al.
Publicado: (2011)

Intraocular Pressure and Anterior Segment Morphometry Changes after Uneventful Phacoemulsification in Type 2 Diabetic and Nondiabetic Patients
por: Beato, João N., et al.
Publicado: (2019)

Structural and Biomechanical Corneal Differences between Type 2 Diabetic and Nondiabetic Patients
por: Beato, João N., et al.
Publicado: (2019)

Evaluation of Corneal Structure and Endothelial Morphological Characteristics in Type 2 Diabetic and Non-Diabetic Patients
por: Beato, João N, et al.
Publicado: (2020)

Ethical Tenets of PRN Medicines Management in Healthcare Settings: A Clinical Perspective
por: Vaismoradi, Mojtaba, et al.
Publicado: (2021)

The Effect of Bevacizumab versus Ranibizumab in the Treatment of Corneal Neovascularization: A Preliminary Study
por: Kim, Jin-Hyoung, et al.
Publicado: (2013)

Intravitreal bevacizumab versus ranibizumab: Effects on the vessels of the fellow non-treated eye
por: Peyman, Mohammadreza, et al.
Publicado: (2018)

Comparison Between Ranibizumab Biosimilar, Innovator Ranibizumab and Bevacizumab in a Real-World Situation
por: Ratra, Dhanashree, et al.
Publicado: (2021)

The Role of Practice Research Networks (PRN) in the Development and Implementation of Evidence: The Northern Improving Access to Psychological Therapies PRN Case Study
por: Lucock, Mike, et al.
Publicado: (2017)

Peripapillary and Subfoveal Choroidal Thickness in Retinal Vein Occlusions [Response to Letter]
por: Moleiro, Ana Filipa, et al.
Publicado: (2023)

Peripapillary and Subfoveal Choroidal Thickness in Retinal Vein Occlusions
por: Moleiro, Ana Filipa, et al.
Publicado: (2022)

Treatment of Neovascular Age-Related Macular Degeneration with Anti-VEGF Agents: Predictive Factors of Long-Term Visual Outcomes
por: Pedrosa, Ana Catarina, et al.
Publicado: (2017)

Hypotony Maculopathy Related to Anti-VEGF Intravitreal Injection
por: Lima-Fontes, Mário, et al.
Publicado: (2022)

Aflibercept versus Ranibizumab as a Second Line Therapy After Bevacizumab for Diabetic Macular Edema
por: Alsaedi, Nasser G, et al.
Publicado: (2021)

Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study
por: Schauwvlieghe, A. M. E., et al.
Publicado: (2016)

A Safety Review and Meta-Analyses of Bevacizumab and Ranibizumab: Off-Label versus Goldstandard
por: Schmucker, Christine, et al.
Publicado: (2012)

Acute anterior uveitis following intravitreal bevacizumab but not subsequent ranibizumab
por: Antonopoulos, Christina, et al.
Publicado: (2011)

Increased Choroidal Thickness in Morquio Syndrome
por: Magalhães, Augusto, et al.
Publicado: (2021)

Ranibizumab Injection for Corneal Neovascularization Refractory to Bevacizumab Treatment
por: Ahn, Ye Jin, et al.
Publicado: (2014)

SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB
por: Avery, Robert L., et al.
Publicado: (2017)

A systematic review and meta-analysis comparing intravitreal ranibizumab with bevacizumab for the treatment of myopic choroidal neovascularisation
por: Loutfi, M., et al.
Publicado: (2015)

Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis
por: Pessoa, Bernardete, et al.
Publicado: (2021)

PRN Medicines Management for Psychotropic Medicines in Long-Term Care Settings: A Systematic Review
por: Vaismoradi, Mojtaba, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b6sd5pgprlko66f6q19ldcinuc